NO923768L - Farmasoeytiske formuleringer - Google Patents

Farmasoeytiske formuleringer

Info

Publication number: NO923768L
Authority: NO; Norway
Prior art keywords: pharmasoeytic; formulations; biologically active; lecithins; bioavailable
Prior art date: 1990-03-29

Application number

NO92923768A

Other languages

English (en)

Norwegian (no)

Other versions

NO923768D0 (no

Inventor

Young W Cho

Michael John Flynn

Thomas Smith Shepherd

Original Assignee

Skua Investments Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-29

Filing date

1992-09-28

Publication date

1992-09-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10673486&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO923768(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-09-28 Application filed by Skua Investments Ltd filed Critical Skua Investments Ltd

1992-09-28 Publication of NO923768D0 publication Critical patent/NO923768D0/no

1992-09-28 Publication of NO923768L publication Critical patent/NO923768L/no

Links

239000000203 mixture Substances 0.000 title abstract 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract 2
102000055006 Calcitonin Human genes 0.000 abstract 1
108060001064 Calcitonin Proteins 0.000 abstract 1
102000003951 Erythropoietin Human genes 0.000 abstract 1
108090000394 Erythropoietin Proteins 0.000 abstract 1
102000018997 Growth Hormone Human genes 0.000 abstract 1
108010051696 Growth Hormone Proteins 0.000 abstract 1
102000004877 Insulin Human genes 0.000 abstract 1
108090001061 Insulin Proteins 0.000 abstract 1
239000011149 active material Substances 0.000 abstract 1
230000000975 bioactive effect Effects 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
229960004015 calcitonin Drugs 0.000 abstract 1
BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
229940105423 erythropoietin Drugs 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 1
239000000122 growth hormone Substances 0.000 abstract 1
229940125396 insulin Drugs 0.000 abstract 1
210000002490 intestinal epithelial cell Anatomy 0.000 abstract 1
239000000787 lecithin Substances 0.000 abstract 1
235000010445 lecithin Nutrition 0.000 abstract 1
230000037361 pathway Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Nanotechnology (AREA)
Crystallography & Structural Chemistry (AREA)
Dispersion Chemistry (AREA)
Medical Informatics (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Diabetes (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO92923768A 1990-03-29 1992-09-28 Farmasoeytiske formuleringer NO923768L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909007052A GB9007052D0 (en)	1990-03-29	1990-03-29	Pharmaceutical formulations
PCT/GB1991/000510 WO1991014454A1 (fr)	1990-03-29	1991-04-02	Formulations pharmaceutiques

Publications (2)

Publication Number	Publication Date
NO923768D0 NO923768D0 (no)	1992-09-28
NO923768L true NO923768L (no)	1992-09-28

Family

ID=10673486

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO92923768A NO923768L (no)	1990-03-29	1992-09-28	Farmasoeytiske formuleringer

Country Status (23)

Country	Link
US (1)	US5665700A (fr)
EP (1)	EP0521994B1 (fr)
JP (1)	JPH05505192A (fr)
KR (1)	KR100197915B1 (fr)
AT (1)	ATE154515T1 (fr)
AU (1)	AU656134B2 (fr)
CA (1)	CA2079233A1 (fr)
CS (1)	CS88091A2 (fr)
DE (1)	DE69126609T2 (fr)
DK (1)	DK0521994T3 (fr)
ES (1)	ES2104697T3 (fr)
FI (1)	FI101043B (fr)
GB (1)	GB9007052D0 (fr)
GR (1)	GR3024745T3 (fr)
HU (2)	HUT63341A (fr)
IE (1)	IE911086A1 (fr)
NO (1)	NO923768L (fr)
NZ (1)	NZ237667A (fr)
PT (1)	PT97199B (fr)
RU (1)	RU2104715C1 (fr)
SG (1)	SG54998A1 (fr)
WO (1)	WO1991014454A1 (fr)
ZA (1)	ZA912411B (fr)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5981485A (en)	1997-07-14	1999-11-09	Genentech, Inc.	Human growth hormone aqueous formulation
US6099856A (en)	1992-06-15	2000-08-08	Emisphere Technologies, Inc.	Active agent transport systems
US6221367B1 (en)	1992-06-15	2001-04-24	Emisphere Technologies, Inc.	Active agent transport systems
US5693338A (en)	1994-09-29	1997-12-02	Emisphere Technologies, Inc.	Diketopiperazine-based delivery systems
US5578323A (en)	1992-06-15	1996-11-26	Emisphere Technologies, Inc.	Proteinoid carriers and methods for preparation and use thereof
US5714167A (en)	1992-06-15	1998-02-03	Emisphere Technologies, Inc.	Active agent transport systems
US5206219A (en) *	1991-11-25	1993-04-27	Applied Analytical Industries, Inc.	Oral compositions of proteinaceous medicaments
CA2094217A1 (fr) *	1992-04-17	1993-10-18	Yasutaka Igari	Composition therapeutique transmucosale
US6916489B2 (en) *	1992-06-15	2005-07-12	Emisphere Technologies, Inc.	Active agent transport systems
DK0955062T3 (da) *	1992-07-31	2007-09-17	Genentech Inc	Vandig formulering indeholdende humant væksthormon
US5464696A (en) *	1992-08-13	1995-11-07	Bracco International B.V.	Particles for NMR imaging
US6461643B2 (en)	1993-04-22	2002-10-08	Emisphere Technologies, Inc.	Oral drug delivery compositions and methods
US20010003001A1 (en) *	1993-04-22	2001-06-07	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5514670A (en) *	1993-08-13	1996-05-07	Pharmos Corporation	Submicron emulsions for delivery of peptides
US5744155A (en) *	1993-08-13	1998-04-28	Friedman; Doron	Bioadhesive emulsion preparations for enhanced drug delivery
WO1995009058A2 (fr) *	1993-09-29	1995-04-06	Technobiochip	Couches minces proteiniques et compositions destinees a leur preparation
WO1995012385A1 (fr) *	1993-11-03	1995-05-11	Isotech Medical, Inc.	Compositions pharmaceutiques microparticulaires sous forme micellaire
DE69535127T2 (de) *	1994-03-18	2007-02-15	Supernus Pharmaceuticals, Inc.	Emulgierte arzneistoffabgabesysteme
US5851510A (en) *	1994-05-16	1998-12-22	The Board Of Regents Of The University Of Michigan	Hepatocyte-selective oil-in-water emulsion
US5858398A (en) *	1994-11-03	1999-01-12	Isomed Inc.	Microparticular pharmaceutical compositions
GB9424902D0 (en) *	1994-12-09	1995-02-08	Cortecs Ltd	Solubilisation Aids
US5989539A (en)	1995-03-31	1999-11-23	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US6001347A (en) *	1995-03-31	1999-12-14	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
CN1151836C (zh)	1995-03-31	2004-06-02	艾米斯菲尔技术有限公司	用作传送活性剂的化合物和组合物
US6090958A (en)	1995-03-31	2000-07-18	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5866536A (en)	1995-03-31	1999-02-02	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5750147A (en)	1995-06-07	1998-05-12	Emisphere Technologies, Inc.	Method of solubilizing and encapsulating itraconazole
WO1997010197A1 (fr)	1995-09-11	1997-03-20	Emisphere Technologies, Inc.	PROCEDE POUR PREPARER DES DERIVES D'ACIDES φ-AMINOALCANOIQUES A PARTIR DE CYCLOALCANONES
US5912014A (en) *	1996-03-15	1999-06-15	Unigene Laboratories, Inc.	Oral salmon calcitonin pharmaceutical products
AU2595697A (en)	1996-03-29	1997-10-22	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US6063370A (en) *	1996-04-05	2000-05-16	The Board Of Trustees Of The University Of Illinois	Macromolecular complexes for drug delivery
WO1997047288A1 (fr)	1996-06-14	1997-12-18	Emisphere Technologies, Inc.	Parfums microencapsules et leur procede de production
DE19724845A1 (de) *	1996-08-28	1998-03-05	Solvay Pharm Gmbh	Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
GB9625589D0 (en)	1996-12-10	1997-01-29	Boots Co Plc	Therapeutic agents
US6313088B1 (en)	1997-02-07	2001-11-06	Emisphere Technologies, Inc.	8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5773647A (en) *	1997-02-07	1998-06-30	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5804688A (en)	1997-02-07	1998-09-08	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5990166A (en)	1997-02-07	1999-11-23	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US6060513A (en)	1997-02-07	2000-05-09	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US6358504B1 (en)	1997-02-07	2002-03-19	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5830432A (en) *	1997-03-31	1998-11-03	Amur Pharmacuticals, Inc.	Phospholipid drug derivatives
US5863944A (en)	1997-04-30	1999-01-26	Emisphere Technologies, Inc.	Compounds and compositions for delivering active agents
US5962710A (en)	1997-05-09	1999-10-05	Emisphere Technologies, Inc.	Method of preparing salicyloylamino acids
US6221378B1 (en)	1998-02-10	2001-04-24	Generex Pharmaceuticals Incorporated	Mixed micellar delivery system and method of preparation
US7070799B1 (en) *	1998-02-10	2006-07-04	Generex Pharmaceuticals, Inc.	Method for administering insulin to the buccal region
US6017545A (en) *	1998-02-10	2000-01-25	Modi; Pankaj	Mixed micellar delivery system and method of preparation
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
SE9801287D0 (sv) *	1998-04-14	1998-04-14	Astra Ab	Incorporation of active substances in carrier matrixes
US7498310B1 (en) *	1998-08-13	2009-03-03	Beiersdorf Ag	Cosmetic or dermatological preparations comprising oligopeptides for lightening the skin of age marks and/or for preventing tanning of the skin, in particular tanning of the skin caused by UV radiation
CN1221249C (zh)	1998-08-19	2005-10-05	斯凯伊药品加拿大公司	普鲁泊福的可注射水分散体
US6290987B1 (en)	1998-09-27	2001-09-18	Generex Pharmaceuticals, Inc.	Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
GB2344520A (en) *	1998-12-08	2000-06-14	Phares Pharm Res Nv	Pharmaceutical carriers comprising lipids and polymers
US6271200B1 (en)	1998-12-21	2001-08-07	Generex Pharmaceuticals Inc.	Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US7087215B2 (en) *	1998-12-21	2006-08-08	Generex Pharmaceuticals Incorporated	Methods of administering and enhancing absorption of pharmaceutical agents
US6849263B2 (en) *	1998-12-21	2005-02-01	Generex Pharmaceutical Incorporated	Pharmaceutical compositions for buccal delivery of pain relief medications
US6436367B1 (en)	1998-12-21	2002-08-20	Generex Pharmaceuticals Inc.	Aerosol formulations for buccal and pulmonary application
AU766745B2 (en) *	1999-03-19	2003-10-23	Generex Pharmaceuticals Inc.	Pharmaceutical solubilized in aerosol propellant
US6350432B1 (en)	1999-03-19	2002-02-26	Generex Pharmaceuticals Incorporated	Pressurized container having an aerosolized pharmaceutical composition
US6956048B2 (en)	1999-03-31	2005-10-18	Pharmacia & Upjohn Company	Pharmaceutical emulsions for retroviral protease inhibitors
NZ534409A (en)	1999-04-05	2006-03-31	Emisphere Tech Inc	Disodium salts, monohydrates, and ethanol solvates for delivering active agents
KR100740794B1 (ko) *	1999-04-09	2007-07-20	오르토-맥네일 파마슈티칼, 인코퍼레이티드	에리트로포이에틴의 약제학적 제형
ATE280571T1 (de) *	1999-08-06	2004-11-15	Max Delbrueck Centrum	Implantierbares wirkstoffdepot
WO2001015720A1 (fr) *	1999-09-02	2001-03-08	Big Bear Bio Inc.	Procedes et compositions servant a limiter les niveaux de phosphate serique
US7129274B1 (en)	1999-11-05	2006-10-31	Emisphere Technologies Inc.	Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en)	1999-11-05	2007-10-09	Emisphere Technologies, Inc.	Phenyl amine carboxylic acid compounds and compositions for delivering active agents
RU2155602C1 (ru) *	1999-11-30	2000-09-10	Оао "Куантум Сатис"	Инсулинсодержащее лекарственное средство для перорального применения и способ его получения
EP1237872B1 (fr)	1999-12-16	2008-02-27	Emisphere Technologies, Inc.	Composes et compositions facilitant l'administration d'agents actifs
US7785625B2 (en)	2000-01-14	2010-08-31	Lg Life Sciences, Limited	Lipophilic-coated microparticle containing a protein drug and formulation comprising same
EP1251867A4 (fr)	2000-02-04	2004-12-08	Unigene Lab Inc	Formulations de calcitonine pour administration par voie nasale
US6417237B1 (en)	2000-06-08	2002-07-09	The Board Of Trustees Of The University Of Illinois	Macromolecular drug complexes and compositions containing the same
US8658202B2 (en)	2001-04-25	2014-02-25	Western University Of Health Sciences	Coated drug delivery formulations
US6759058B1 (en) *	2001-04-25	2004-07-06	Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences	Enteric-coated proliposomal formulations for poorly water soluble drugs
US7758893B2 (en)	2001-07-27	2010-07-20	N.V. Nutricia	Enteral compositions for the prevention and/or treatment of sepsis
US6951655B2 (en) *	2001-10-11	2005-10-04	Imi Biomed, Inc.	Pro-micelle pharmaceutical compositions
KR100441167B1 (ko) *	2001-12-27	2004-07-21	씨제이 주식회사	마이크로에멀젼 예비 농축액 조성물
WO2004032789A2 (fr) *	2002-10-09	2004-04-22	The Azza Co., Ltd.	Composition liposomale d'hormone de croissance humaine (hch) et procede d'administration associe
US8088734B2 (en)	2003-01-21	2012-01-03	Unigene Laboratories Inc.	Oral delivery of peptides
US8211448B2 (en) *	2003-07-07	2012-07-03	Nares Ab	Microemulsions and its use for preventing airway diseases
JP2005209106A (ja) *	2004-01-26	2005-08-04	Nec Corp	携帯通信端末、受信メール管理方法、プログラムおよび記録媒体
US8236861B2 (en) *	2004-02-13	2012-08-07	Hormos Medical Corporation	Method for enhancing the bioavailablity of ospemifene
CA2560613C (fr)	2004-03-22	2015-11-24	Solvay Pharmaceuticals Gmbh	Compositions pharmaceutiques par voie orale a base de lipases, en particulier de pancreatine, contenant des tensioacitfs
US8449867B2 (en) *	2004-08-31	2013-05-28	Stiefel Research Australia Pty Ltd	Microemulsion and sub-micron emulsion process and compositions
TWI397427B (zh) *	2004-08-31	2013-06-01	史迪費爾研究澳洲股份有限公司	微乳化液、次微米乳化液的方法及組成物
EP1652513A1 (fr) *	2004-11-02	2006-05-03	Denderah Pharm Sa	Micelles inversées basés sur des stérols et des acylglycerols and leur utilisation thérapeutique
GB0428515D0 (en) *	2004-12-30	2005-02-09	Unilever Plc	Edible compositions and their preparation
US9198871B2 (en)	2005-08-15	2015-12-01	Abbott Products Gmbh	Delayed release pancreatin compositions
US11266607B2 (en)	2005-08-15	2022-03-08	AbbVie Pharmaceuticals GmbH	Process for the manufacture and use of pancreatin micropellet cores
EP2722054B1 (fr)	2005-09-06	2018-03-21	Oramed Pharmaceuticals Inc.	Procédés et compositions pour l'administration orale de protéines
US10072256B2 (en)	2006-05-22	2018-09-11	Abbott Products Gmbh	Process for separating and determining the viral load in a pancreatin sample
DE102006056783A1 (de) *	2006-12-01	2008-06-05	Lts Lohmann Therapie-Systeme Ag	Zubereitung zur transdermalen Verabreichung von Galanthamin
RU2411039C2 (ru) *	2007-12-26	2011-02-10	Валентина Васильевна Малиновская	Иммунокорригирующее средство для лечения заболеваний вирусной этиологии
RU2367472C1 (ru) *	2008-03-17	2009-09-20	Общество С Ограниченной Ответственностью "Технология Лекарств"	Парентеральное лекарственное средство и способ его получения
RU2504373C2 (ru)	2008-03-26	2014-01-20	ОРАМЕД Лтд.	Способы и композиции для перорального введения протеинов
CA2723434C (fr)	2008-05-05	2018-01-23	Oramed Ltd.	Procedes et compositions pour l'administration d'exenatide par voie orale
WO2010050918A1 (fr) *	2008-10-31	2010-05-06	Qinghai Zhang	Détergents à chaîne ramifiée pour la biologie structurale de protéine membranaire
US20140154377A1 (en) *	2011-04-04	2014-06-05	Dsm Ip Assets B.V.	Oil-in-water emulsions comprising a polyunsaturated fatty acid and methods of making the same
WO2013102899A1 (fr)	2012-01-03	2013-07-11	Oramed Ltd.	Procédés et compositions pour le traitement du diabète
ES2912138T3 (es)	2012-02-01	2022-05-24	Oramed Ltd	Composiciones que contienen inhibidores de proteasa, composiciones que comprenden las mismas y métodos para producir y usar las misma
CN104902921A (zh)	2013-01-03	2015-09-09	奥拉姆德有限公司	用于治疗nafld、肝性脂肪变性及其后遗症的方法和组合物
EP3820455B1 (fr) *	2018-07-10	2024-06-19	Universidade de Santiago de Compostela	Systèmes lipidiques à nanostructure

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1180996A (en) *	1967-08-30	1970-02-11	Inst Rech S Chimiques Et Biolo	Solubilised Cytochrome C-phospholipid Complexes
US4164573A (en) *	1975-06-13	1979-08-14	Galinsky Alvin M	Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
JPS5517328A (en) *	1978-07-21	1980-02-06	Tanabe Seiyaku Co Ltd	Insulin-containing emulsion and its preparation
JPS5770814A (en) *	1980-10-17	1982-05-01	Isamu Horikoshi	Oral preparation of blood clotting eighth factor
NL193099C (nl) *	1981-10-30	1998-11-03	Novo Industri As	Gestabiliseerde insuline-oplossing.
JPS6058915A (ja) *	1983-09-12	1985-04-05	Fujisawa Pharmaceut Co Ltd	薬物含有脂質小胞体製剤
FR2581543B1 (fr) *	1985-05-09	1989-07-07	Tressens Dominique	Pharmacotechnie permettant la realisation d'une preparation insulinique active par voie orale
US4849227A (en) *	1986-03-21	1989-07-18	Eurasiam Laboratories, Inc.	Pharmaceutical compositions
EP0302065B1 (fr) *	1986-03-21	1994-08-10	Eurasiam Laboratories, Inc.	Compositions pharmaceutiques
NZ222907A (en) *	1986-12-16	1990-08-28	Novo Industri As	Preparation for intranasal administration containing a phospholipid absorption enhancing system
AU598958B2 (en) *	1987-11-12	1990-07-05	Vestar, Inc.	Improved amphotericin b liposome preparation

1990
- 1990-03-29 GB GB909007052A patent/GB9007052D0/en active Pending
1991
- 1991-03-28 IE IE108691A patent/IE911086A1/en unknown
- 1991-03-28 ZA ZA912411A patent/ZA912411B/xx unknown
- 1991-03-28 PT PT97199A patent/PT97199B/pt not_active IP Right Cessation
- 1991-03-29 CS CS91880A patent/CS88091A2/cs unknown
- 1991-04-02 DE DE69126609T patent/DE69126609T2/de not_active Revoked
- 1991-04-02 AU AU75842/91A patent/AU656134B2/en not_active Ceased
- 1991-04-02 DK DK91907052.4T patent/DK0521994T3/da active
- 1991-04-02 CA CA002079233A patent/CA2079233A1/fr not_active Abandoned
- 1991-04-02 KR KR1019920070234A patent/KR100197915B1/ko not_active Expired - Lifetime
- 1991-04-02 ES ES91907052T patent/ES2104697T3/es not_active Expired - Lifetime
- 1991-04-02 RU SU5053188A patent/RU2104715C1/ru active
- 1991-04-02 EP EP91907052A patent/EP0521994B1/fr not_active Revoked
- 1991-04-02 HU HU9330A patent/HUT63341A/hu unknown
- 1991-04-02 JP JP3506507A patent/JPH05505192A/ja active Pending
- 1991-04-02 AT AT91907052T patent/ATE154515T1/de not_active IP Right Cessation
- 1991-04-02 SG SG1996000854A patent/SG54998A1/en unknown
- 1991-04-02 WO PCT/GB1991/000510 patent/WO1991014454A1/fr not_active Ceased
- 1991-04-03 NZ NZ237667A patent/NZ237667A/en unknown
1992
- 1992-09-28 FI FI924340A patent/FI101043B/fi active
- 1992-09-28 NO NO92923768A patent/NO923768L/no unknown
1994
- 1994-08-15 US US08/290,293 patent/US5665700A/en not_active Expired - Fee Related
1995
- 1995-06-30 HU HU95P/P00724P patent/HU211962A9/hu unknown
1997
- 1997-09-17 GR GR970402390T patent/GR3024745T3/el unknown

Also Published As

Publication number	Publication date
DE69126609T2 (de)	1998-01-02
JPH05505192A (ja)	1993-08-05
ZA912411B (en)	1992-11-25
FI924340A0 (fi)	1992-09-28
AU7584291A (en)	1991-10-21
HU211962A9 (en)	1996-01-29
HU9203093D0 (en)	1992-12-28
AU656134B2 (en)	1995-01-27
DE69126609D1 (de)	1997-07-24
PT97199A (pt)	1991-11-29
PT97199B (pt)	1998-07-31
EP0521994B1 (fr)	1997-06-18
SG54998A1 (en)	1998-12-21
HK1004531A1 (en)	1998-11-27
IE911086A1 (en)	1991-10-09
KR100197915B1 (ko)	1999-06-15
WO1991014454A1 (fr)	1991-10-03
FI924340L (fi)	1992-09-28
DK0521994T3 (da)	1997-07-07
GB9007052D0 (en)	1990-05-30
NO923768D0 (no)	1992-09-28
FI101043B (fi)	1998-04-15
CS88091A2 (en)	1991-11-12
ATE154515T1 (de)	1997-07-15
RU2104715C1 (ru)	1998-02-20
HUT63341A (en)	1993-08-30
NZ237667A (en)	1994-01-26
GR3024745T3 (en)	1997-12-31
EP0521994A1 (fr)	1993-01-13
CA2079233A1 (fr)	1991-09-30
US5665700A (en)	1997-09-09
ES2104697T3 (es)	1997-10-16

Publication	Publication Date	Title
DK0521994T3 (da)	1997-07-07	Farmaceutiske formuleringer
WO1990003164A3 (fr)	1990-06-14	Formulations pharmaceutiques
LV10196A (lv)	1994-10-20	Olbaltumviela biologiski aktivais hormons olbaltumvielas iegusanas panemiens farmaceitisks preparats
PT693924E (pt)	2004-09-30	Processos para administracao (in vivo) de substancias biologicas e composicoes utilizadas nestes processos
IL88460A0 (en)	1989-06-30	Stabilized medicinal substances,a process for the preparation thereof,and stable medicinal formulations
DE3678661D1 (de)	1991-05-16	Arzneimittel mit langsamer wirkstofffreisetzung.
DE69631881D1 (de)	2004-04-22	Pulmonale verabreichung von medikamenten in aerosolform
NO903542L (no)	1991-02-15	Frysetoerket blanding og fremgangsmaate for oral administrering av legemidler, naeringsmidler og biologisk aktive materialer.
CA2033725A1 (fr)	1991-07-25	Compositions pharmaceutiques et cosmetiques
DE3886880D1 (de)	1994-02-17	Pulverförmige Zubereitungen zur intranasalen Verabreichung von Polypeptiden.
DE69637961D1 (de)	2009-08-13	Verabreichung von biologisch aktiven polypeptiden
FI943563L (fi)	1994-07-29	Uusia biologisesti aktiivisia polypeptidejä, niiden valmistus ja niitä sisältävä farmaseuttinen koostumus
SE8504945L (sv)	1986-04-23	Farmaceutiska kompositioner innehallande antracyklinglykosider
FI963424A0 (fi)	1996-09-02	Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
ES2159524T3 (es)	2001-10-16	Preparacion farmaceutica para administrarse en el interior de las vias respiratorias.
DE3676235D1 (de)	1991-01-31	Arzneizubereitung mit verzoegerter wirkstoffabgabe.
BR9401199A (pt)	1994-10-18	Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
NZ225066A (en)	1990-07-26	Solid drug preparations containing 2-phenyl-1,2-benzisoselenazol-3(2h)-one (ebselen)
ES2058988T3 (es)	1994-11-01	Preparacion de medicamentos para el tratamiento sistemico de peces ornamentales y utiles.
NO179436C (no)	1996-10-09	Fremgangsmåte for fremstilling av farmasöytiske produkter for topisk bruk
FI864164A7 (fi)	1987-04-18	Ihmis- -interferonin biologisesti aktiivisia johdoksia, niiden valmistus ja tällaisia johdoksia sisältävlääkkeitä.
IT1171091B (it)	1987-06-10	Derivati di 2,5-piperazindione biologicamente attivi,processi per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI911059A1 (it)	1992-10-17	Acido metiltauroursodesossicolico e suoi derivati terapeuticamente attivi procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
ES8303915A1 (es)	1983-03-01	"procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
IT8748490A0 (it)	1987-10-13	Procedimento per la preparazione di derivati di zuccheri e peptidi biologicamente attivi e prodotto ottenuto